prostate cancer gene therapy (Regulon/IntelliGene)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameprostate cancer gene therapy (Regulon/IntelliGene)

Drug Alias NameLipoIPSA

ClassificationCell and gene therapy > Gene therapy

Mechanisms of ActionCaspase modulators

TargetsCaspase

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesIsrael

CombinationsNo

Global Highest StatusPending

Highest Status in ChinaN/A

Originator CompaniesRegulon

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesIntelligene Regulon

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

ATC CodeN/A